uBiome

Private

uBiome was a biotechnology company that developed technology to sequence and analyze the human microbiome using proprietary machine-learning algorithms. The company offered consumer testing kits and clinical diagnostics (SmartGut, SmartJane) reimbursed by health insurance. uBiome collapsed in 2019 after an FBI raid over healthcare fraud, with its co-founders later indicted for defrauding investors and insurers.

Founders Jessica Richman, Zachary Apte

CEO Jessica Richman

Company

Founded

2012

Headquarters

San Francisco, United States

Employees

51-200

Financials

Total Funding

$110M

Last Valuation

$600M

Sectors

Biotech

ubiome.com Twitter

Funding History

3 rounds

Series C Sep 21, 2018

$83M

Valuation: $600M

OS Fund (Lead) 8VC Y Combinator Dentsu Ventures

Series B Nov 1, 2016

$22M

8VC (Lead) Slow Ventures StartX

Seed Aug 18, 2014

$5M

Andreessen Horowitz (Lead) Y Combinator

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.